NCT00002197View on ClinicalTrials.gov

A Study of 1592U89 in HIV-Infected Children

NACompletedINTERVENTIONAL

Enrollment

250

Participants

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

Abacavir sulfate

Trial Locations (1)

277093398

Glaxo Wellcome Inc, Research Triangle Park

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Glaxo Wellcome

INDUSTRY

NCT00002197 - A Study of 1592U89 in HIV-Infected Children | Biotech Hunter | Biotech Hunter